These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30693676)

  • 41. Computational insights into β-site amyloid precursor protein enzyme 1 (BACE1) inhibition by tanshinones and salvianolic acids from Salvia miltiorrhiza via molecular docking simulations.
    Yu T; Paudel P; Seong SH; Kim JA; Jung HA; Choi JS
    Comput Biol Chem; 2018 Jun; 74():273-285. PubMed ID: 29679864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
    Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
    Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities.
    De Tran Q; Bepary S; Lee GH; Cho H; Park WK; Lim HJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):51-4. PubMed ID: 26608551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational methods in the discovery and design of BACE-1 inhibitors.
    Kacker P; Bottegoni G; Cavalli A
    Curr Med Chem; 2012; 19(36):6095-111. PubMed ID: 23072352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ligand retargeting by binding site analogy.
    Wiedmer L; Schärer C; Spiliotopoulos D; Hürzeler M; Śledź P; Caflisch A
    Eur J Med Chem; 2019 Aug; 175():107-113. PubMed ID: 31077996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and biological evaluation of conformationally constrained BACE1 inhibitors.
    Winneroski LL; Schiffler MA; Erickson JA; May PC; Monk SA; Timm DE; Audia JE; Beck JP; Boggs LN; Borders AR; Boyer RD; Brier RA; Hudziak KJ; Klimkowski VJ; Garcia Losada P; Mathes BM; Stout SL; Watson BM; Mergott DJ
    Bioorg Med Chem; 2015 Jul; 23(13):3260-8. PubMed ID: 26001341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
    Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A stereoselective approach to peptidomimetic BACE1 inhibitors.
    Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
    Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
    Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
    Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BACE1 Inhibition by Genistein: Biological Evaluation, Kinetic Analysis, and Molecular Docking Simulation.
    Youn K; Park JH; Lee S; Lee S; Lee J; Yun EY; Jeong WS; Jun M
    J Med Food; 2018 Apr; 21(4):416-420. PubMed ID: 29444415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.
    Jain P; Wadhwa PK; Rohilla S; Jadhav HR
    Bioorg Med Chem Lett; 2016 Jan; 26(1):33-7. PubMed ID: 26614409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl)-amides as BACE1 inhibitors: a patent evaluation of WO2013041499.
    Dessolin J
    Expert Opin Ther Pat; 2014 Feb; 24(2):239-42. PubMed ID: 24219148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Constant pH Molecular Dynamics Reveals pH-Modulated Binding of Two Small-Molecule BACE1 Inhibitors.
    Ellis CR; Tsai CC; Hou X; Shen J
    J Phys Chem Lett; 2016 Mar; 7(6):944-9. PubMed ID: 26905811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
    Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
    Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads.
    Manoharan P; Ghoshal N
    J Biomol Struct Dyn; 2018 May; 36(7):1878-1892. PubMed ID: 28617091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospecting and Structural Insight into the Binding of Novel Plant-Derived Molecules of Leea indica as Inhibitors of BACE1.
    Hosen SMZ; Rubayed M; Dash R; Junaid M; Mitra S; Alam MS; Dey R
    Curr Pharm Des; 2018; 24(33):3972-3979. PubMed ID: 30398111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.